Location of Repository

The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study

By Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan and Andreas Obermair
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3337811
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2005). al: Prognostic importance of preoperative
    2. (2009). Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study.
    3. (2000). Berek JS: Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol
    4. Cancer Incidence and Mortality Worldwide:
    5. (2005). Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol
    6. (2005). Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients. Anticancer Res
    7. (2005). Evaluation of progression according to CA 125: definitions agreed by GCIG
    8. FE: Patterns of postoperative surveillance for ovarian cancer: What we do and why we do it.
    9. (2006). Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels. Gynecol Oncol
    10. (1996). HE: Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. J Clin Oncol
    11. (2006). MF: CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. Ann Oncol
    12. (2008). MF: Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study. Gynecol Oncol
    13. National Comprehensive Cancer Network: Uterine neoplasms.
    14. (2007). Professionals’ and patients’ views of routine follow-up: a questionnaire survey.
    15. (2009). Routine follow-up after treatment for ovarian cancer in the United Kingdom (UK): patient and health professional views. Eur J Oncol Nurs
    16. (2008). The role of regular physical examination in the detection of ovarian cancer recurrence. Gynecol Oncol

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.